BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Li-Wang Zhang, Jun Ren, Liang Zhang, Hong-Mei Zhang, Bin Jin, Bo-Rong Pan, Xiao-Ming Si, Yan-Jun Zhang, Zhong-Hua Wang, Yang-Lin Pan, Stephen M Festein. Construction and expression of recombined human AFP eukaryotic expression vectorWorld Journal of Gastroenterology 2003; 9(7): 1465-1468 doi: 10.3748/wjg.v9.i7.1465
2
Lun-Xiu Qin, Zhao-You Tang. The prognostic molecular markers in hepatocellular carcinomaWorld Journal of Gastroenterology 2002; 8(3): 385-392 doi: 10.3748/wjg.v8.i3.385
3
Giovanni Ramacciato, Paolo Mercantini, Nicola Cautero, Nicola Corigliano, Fabrizio Di Benedetto, Cristiano Quintini, Giorgio Ercolani, Giovanni Varotti, Vincenzo Ziparo, Antonio Daniele Pinna. Prognostic Evaluation of the New American Joint Committee on Cancer/International Union Against Cancer Staging System for Hepatocellular Carcinoma: Analysis of 112 Cirrhotic Patients Resected for Hepatocellular CarcinomaAnnals of Surgical Oncology 2005; 12(4): 289 doi: 10.1245/ASO.2005.03.098
4
Fu-Ping Zhong, Yu-Jun Zhang, Ying Liu, Shu-Bing Zou. Prognostic impact of surgical margin in patients with hepatocellular carcinomaMedicine 2017; 96(37): e8043 doi: 10.1097/MD.0000000000008043
5
Antony Lawrence Gough-Palmer, Wladyslaw Michal Witold Gedroyc. Laser ablation of hepatocellular carcinoma-A reviewWorld Journal of Gastroenterology 2008; 14(47): 7170-7174 doi: 10.3748/wjg.14.7170
6
T.W. Chen, C.M. Chu, J.C. Yu, C.J. Chen, D.C. Chan, Y.C. Liu, C.B. Hsieh. Comparison of clinical staging systems in predicting survival of hepatocellular carcinoma patients receiving major or minor hepatectomyEuropean Journal of Surgical Oncology (EJSO) 2007; 33(4): 480 doi: 10.1016/j.ejso.2006.10.012
7
Courtney Scaife. Surgery2008; : 943 doi: 10.1007/978-0-387-68113-9_49
8
Yun-Le Wan, Shu-Sen Zheng, Zhi-Cheng Zhao, Min-Wei Li, Chang-Ku Jia, Hao Zhang. Expression of co-stimulator 4-1BB molecule in hepatocellular carcinoma and adjacent non-tumor liver tissue, and its possible role in tumor immunityWorld Journal of Gastroenterology 2004; 10(2): 195-199 doi: 10.3748/wjg.v10.i2.195
9
Da Xu, Jessica Qiuhua Sheng, Paul Jen-Hwa Hu, Ting Shuo Huang, Wei-Chen Lee. Predicting hepatocellular carcinoma recurrences: A data-driven multiclass classification method incorporating latent variablesJournal of Biomedical Informatics 2019; 96: 103237 doi: 10.1016/j.jbi.2019.103237
10
N Griffin, H Addley, E Sala, A S Shaw, L A Grant, H Eldaly, S E Davies, T Prevost, G J Alexander, D J Lomas. Vascular invasion in hepatocellular carcinoma: is there a correlation with MRI?The British Journal of Radiology 2012; 85(1014): 736 doi: 10.1259/bjr/94924398
11
Jay L. Grosfeld, Jean-Bernard Otte. The Surgery of Childhood Tumors2008; : 227 doi: 10.1007/978-3-540-29734-5_12
12
Melanie B. Thomas, Romil Chadha, Katrina Glover, Xuemei Wang, Jeffrey Morris, Thomas Brown, Asif Rashid, Janet Dancey, James L. Abbruzzese. Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinomaCancer 2007; 110(5): 1059 doi: 10.1002/cncr.22886
13
C. CAMMÀ, V. DI MARCO, G. CABIBBO, F. LATTERI, L. SANDONATO, P. PARISI, M. ENEA, M. ATTANASIO, M. GALIA, N. ALESSI, A. LICATA, M. A. LATTERI, A. CRAXÌ. Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systemsAlimentary Pharmacology & Therapeutics 2008; 28(1): 62 doi: 10.1111/j.1365-2036.2008.03692.x
14
M.C. Jansen, R. van Hillegersberg, R.A.F.M. Chamuleau, O.M. van Delden, D.J. Gouma, T.M. van Gulik. Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective reviewEuropean Journal of Surgical Oncology (EJSO) 2005; 31(4): 331 doi: 10.1016/j.ejso.2004.10.011
15
Charing Ching-Ning Chong, Kit-fai Lee, Philip Ching-Tak Ip, Jeff Siu-Wang Wong, Sunny Yue-Sun Cheung, John Wong, Suzanne C. Ho, Paul Bo-San Lai. Pre-operative predictors of post-hepatectomy recurrence of hepatocellular carcinoma: Can we predict earlier?The Surgeon 2012; 10(5): 260 doi: 10.1016/j.surge.2011.07.004
16
Nouha Dilou, Brigitte Patouillard, Jean-Christian Audigier. Les classifications de prédiction de survie du carcinome hépatocellulaireGastroentérologie Clinique et Biologique 2004; 28(4): 359 doi: 10.1016/S0399-8320(04)94936-6
17
Irene Bargellini. Hepatocellular carcinoma: MR staging and therapeutic decisionsAbdominal Imaging 2012; 37(2): 231 doi: 10.1007/s00261-011-9735-8
18
Benyam D. Addissie, Lewis R. Roberts. Classification and Staging of Hepatocellular CarcinomaClinics in Liver Disease 2015; 19(2): 277 doi: 10.1016/j.cld.2015.01.011
19
Ken Shirabe, Kiyoshi Kajiyama, Norifumi Harimoto, Hideaki Masumoto, Tatsuro Fukuya, Masafumi Ooya, Yoshihiko Maehara. Prognosis of hepatocellular carcinoma accompanied by microscopic portal vein invasionWorld Journal of Gastroenterology 2009; 15(21): 2632-2637 doi: 10.3748/wjg.15.2632
20
Bruno Daniele, Francesco Perrone. Staging for Liver CancerClinics in Liver Disease 2005; 9(2): 213 doi: 10.1016/j.cld.2004.12.003
21
Alfredo Guglielmi, Andrea Ruzzenente, Marco Sandri, Silvia Pachera, Corrado Pedrazzani, Sebastiano Tasselli, Calogero Iacono. Radio Frequency Ablation for Hepatocellular Carcinoma in Cirrhotic Patients: Prognostic Factors for SurvivalJournal of Gastrointestinal Surgery 2007; 11(2): 143 doi: 10.1007/s11605-006-0082-y
22
Kit Fai Lee, Ching Ning Chong, Jeff Wong, Yue Sun Cheung, John Wong, Paul Lai. Long-Term Results of Laparoscopic Hepatectomy Versus Open Hepatectomy for Hepatocellular Carcinoma: A Case-Matched AnalysisWorld Journal of Surgery 2011; 35(10): 2268 doi: 10.1007/s00268-011-1212-6
23
Wu Ji, Jie-Shou Li, Ling-Tang Li, Wu-Hong Liu, Kuan-Sheng Ma, Xiang-Tian Wang, Zhen-Ping He, Jia-Hong Dong. Role of preoperative selective portal vein embolization in two-step curative hepatectomy for hepatocellular carcinomaWorld Journal of Gastroenterology 2003; 9(8): 1702-1706 doi: 10.3748/wjg.v9.i8.1702
24
Ahmed Gabr, Nadine Abouchaleh, Rehan Ali, Michael Vouche, Rohi Atassi, Khairuddin Memon, Ali Al Asadi, Talia Baker, Juan Carlos Caicedo, Kush Desai, Jonathan Fryer, Ryan Hickey, Michael Abeccassis, Ali Habib, Elias Hohlastos, Daniel Ganger, Laura Kulik, Robert J. Lewandowski, Ahsun Riaz, Riad Salem. Comparative study of post-transplant outcomes in hepatocellular carcinoma patients treated with chemoembolization or radioembolizationEuropean Journal of Radiology 2017; 93: 100 doi: 10.1016/j.ejrad.2017.05.022
25
Sene Waly Raphael, Zhang Yangde, Chen YuXiang. Hepatocellular Carcinoma: Focus on Different Aspects of ManagementISRN Oncology 2012; 2012: 1 doi: 10.5402/2012/421673
26
Ivan Fan-Ngai Hung, Danny Ka-Ho Wong, Ronnie Tung-Ping Poon, Daniel Yee-Tak Fong, Ada Hang-Wai Chui, Wai-Kay Seto, James Yan-Yue Fung, Albert Chi-Yan Chan, John Chi-Hang Yuen, Randal Tiu, Olivia Choi, Ching-Lung Lai, Man-Fung Yuen, Ming-Lung Yu. Risk Factors and Post-Resection Independent Predictive Score for the Recurrence of Hepatitis B-Related Hepatocellular CarcinomaPLOS ONE 2016; 11(2): e0148493 doi: 10.1371/journal.pone.0148493
27
Ferenc Szalay, Mónika B Hantos, Andrea Horvath, Peter L. Lakatos, Aniko Folhoffer, Kinga Dunkel, Dalma Hegedus, Kornélia Tekes. Increased nociceptin/orphanin FQ plasma levels in hepatocellular carcinomaWorld Journal of Gastroenterology 2004; 10(1): 42-45 doi: 10.3748/wjg.v10.i1.42
28
Zhi-Ming Li, Zong-Chao Liu, Zhong-Zhen Guan, Xiao-Feng Zhu, Jun-Min Zhou, Bing-Fen Xie, Gong-Kan Feng, Zhen-Yu Zhu, Wen-Qi Jiang. Inhibition of DNA primase and induction of apoptosis by 3,3’-diethyl-9-methylthia-carbocyanine iodide in hepatocellular carcinoma BEL-7402 cellsWorld Journal of Gastroenterology 2004; 10(4): 514-520 doi: 10.3748/wjg.v10.i4.514
29
Shao-Hua Peng, Hong Deng, Jian-Feng Yang, Ping-Ping Xie, Cheng Li, Hao Li, De-Yun Feng. Significance and relationship between infiltrating inflammatory cell and tumor angiogenesis in hepatocellular carcinoma tissuesWorld Journal of Gastroenterology 2005; 11(41): 6521-6524 doi: 10.3748/wjg.v11.i41.6521
30
Shao-Shan Wang, Ti Zhang, Xi-Lu Wang, Li Hong, Qing-Hui Qi. Effect of arsenic trioxide on rat hepatocarcinoma and its renal cytotoxicityWorld Journal of Gastroenterology 2003; 9(5): 930-935 doi: 10.3748/wjg.v9.i5.930
31
Chunwang Yuan, Zhenchang Wang, Dongsheng Gu, Jie Tian, Peng Zhao, Jingwei Wei, Xiaozhen Yang, Xiaohan Hao, Di Dong, Ning He, Yu Sun, Wenfeng Gao, Jiliang Feng. Prediction early recurrence of hepatocellular carcinoma eligible for curative ablation using a Radiomics nomogramCancer Imaging 2019; 19(1) doi: 10.1186/s40644-019-0207-7
32
Claudio Maurizio Pacella, Giampiero Francica, Giovanni Giuseppe Di Costanzo. Laser Ablation for Small Hepatocellular CarcinomaRadiology Research and Practice 2011; 2011: 1 doi: 10.1155/2011/595627
33
Zhao-Chong Zeng, Guo-Liang Jiang, Guo-Min Wang, Zhao-You Tang, Walter J. Curran, George Iliakis. DNA-PKcs subunits in radiosensitization by hyperthermia on hepatocellular carcinoma hepG2 cell lineWorld Journal of Gastroenterology 2002; 8(5): 797-803 doi: 10.3748/wjg.v8.i5.797
34
Yoshito Tomimaru, Hidetoshi Eguchi, Hiroshi Wada, Shogo Kobayashi, Shigeru Marubashi, Masahiro Tanemura, Koji Umeshita, Tonsok Kim, Kenichi Wakasa, Yuichiro Doki, Masaki Mori, Hiroaki Nagano. IGFBP7 downregulation is associated with tumor progression and clinical outcome in hepatocellular carcinomaInternational Journal of Cancer 2012; 130(2): 319 doi: 10.1002/ijc.25994
35
Mitsuru Ishizuka, Keiichi Kubota, Junji Kita, Mitsugi Shimoda, Masato Kato, Tokihiko Sawada. Survival after surgery for hepatocellular carcinoma in relation to presence or absence of viral infectionThe American Journal of Surgery 2013; 206(2): 187 doi: 10.1016/j.amjsurg.2012.08.011
36
A. Nanashima, S. Morino, H. Yamaguchi, K. Tanaka, S. Shibasaki, T. Tsuji, S. Hidaka, T. Sawai, T. Yasutake, T. Nakagoe. Modified CLIP using PIVKA-II for evaluating prognosis after hepatectomy for hepatocellular carcinomaEuropean Journal of Surgical Oncology (EJSO) 2003; 29(9): 735 doi: 10.1016/j.ejso.2003.08.007
37
Alfredo Guglielmi, Andrea Ruzzenente, Silvia Pachera, Alessandro Valdegamberi, Marco Sandri, Mirko D'Onofrio, Calogero Iacono. Comparison of Seven Staging Systems in Cirrhotic Patients With Hepatocellular Carcinoma in a Cohort of Patients Who Underwent Radiofrequency Ablation With Complete ResponseThe American Journal of Gastroenterology 2008; 103(3): 597 doi: 10.1111/j.1572-0241.2007.01604.x
38
Sha Huang, Gui-Qian Huang, Gui-Qi Zhu, Wen-Yue Liu, Jie You, Ke-Qing Shi, Xiao-Bo Wang, Han-Yang Che, Guo-Liang Chen, Jian-Feng Fang, Yi Zhou, Meng-Tao Zhou, Yong-Ping Chen, Martin Braddock, Ming-Hua Zheng, Chien-Wei Su. Establishment and Validation of SSCLIP Scoring System to Estimate Survival in Hepatocellular Carcinoma Patients Who Received Curative Liver ResectionPLOS ONE 2015; 10(6): e0129000 doi: 10.1371/journal.pone.0129000
39
Wen-Jiao Zeng, Guo-Yuan Liu, Jie Xu, Xin-Da Zhou, Yue-E Zhang, Nong Zhang. Pathological characteristics, PCNA labeling index and DNA index in prognostic evaluation of patients with moderately differentiated hepatocellular carcinomaWorld Journal of Gastroenterology 2002; 8(6): 1040-1044 doi: 10.3748/wjg.v8.i6.1040
40
Jonathan Olesinski, François Mithieux, Olivier Guillaud, Marie-Noëlle Hilleret, Catherine Lombard-Bohas, Luc Henry, Olivier Boillot, Thomas Walter, Christian Partensky, Pierre Paliard, Pierre-Jean Valette, Jean-Philippe Vuillez, Françoise Borson-Chazot, Jean-Yves Scoazec, Jérôme Dumortier. Survival and prognostic factors after adjuvant 131iodine-labeled lipiodol for hepatocellular carcinoma: a retrospective analysis of 106 patients over 20 yearsAnnals of Nuclear Medicine 2017; 31(5): 379 doi: 10.1007/s12149-017-1165-4
41
Bruno Daniele, Mena Annunziata, Emiddio Barletta, Vincenza Tinessa, Massimo Di Maio. Cancer of the Liver Italian Program (CLIP) score for staging hepatocellular carcinomaHepatology Research 2007; 37(s2 Fourth JSH S): S206 doi: 10.1111/j.1872-034X.2007.00186.x
42
E. Giannini, D. Risso, F. Botta, P. Romagnoli, F. Malfatti, A. Fumagalli, E. Testa, E. Podesta, B. Chiarbonello, S. Polegato, R. Testa. Prognosis of hepatocellular carcinoma in anti-HCV positive cirrhotic patients: a single-centre comparison amongst four different staging systemsJournal of Internal Medicine 2004; 255(3): 399 doi: 10.1046/j.1365-2796.2003.01284.x
43
Clifford S. Cho, Mithat Gonen, Jinru Shia, Michael W. Kattan, David S. Klimstra, William R. Jarnagin, Michael I. D’Angelica, Leslie H. Blumgart, Ronald P. DeMatteo. A Novel Prognostic Nomogram Is More Accurate than Conventional Staging Systems for Predicting Survival after Resection of Hepatocellular CarcinomaJournal of the American College of Surgeons 2008; 206(2): 281 doi: 10.1016/j.jamcollsurg.2007.07.031
44
Ji Yeon Seo, Won Kim, Jee Hye Kwon, Eun Hyo Jin, Su Jong Yu, Hwi Young Kim, Yong Jin Jung, Donghee Kim, Yoon Jun Kim, Jung-Hwan Yoon, Hyo-Suk Lee. Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablationLiver International 2013; 33(6): 884 doi: 10.1111/liv.12132
45
Morris Sherman. Staging for hepatocellular carcinomaCurrent Hepatitis Reports 2004; 3(2): 61 doi: 10.1007/s11901-004-0011-z
46
Ken Shirabe, Kiyoshi Kajiyama, Tomoyuki Abe, Shigeru Sakamoto, Tatsuro Fukuya, Kohei Akazawa, Kazutoyo Morita, Yoshihiko Maehara. Predictors of microscopic portal vein invasion by hepatocellular carcinoma: Measurement of portal perfusion defect area ratioJournal of Gastroenterology and Hepatology 2009; 24(8): 1431 doi: 10.1111/j.1440-1746.2009.05847.x
47
Lian-Xin Liu, Zhi-Hua Liu, Hong-Chi Jiang, Wei-Hui Zhang, Shu-Yi Qi, Jie Hu, Xiu-Qin Wang, Min Wu. Gene expression profiles of hepatoma cell line HLEWorld Journal of Gastroenterology 2003; 9(4): 683-687 doi: 10.3748/wjg.v9.i4.683